Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P010003/S043

BioGlue Surgical Adhesive

Cryolife, Inc. · Decision date Jul 15, 2026

FDA DECISIONP010003/S043

What did the FDA approve?

FDA records P010003/S043 as a supplement to PMA P010003, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Jul 15, 2026.

FDA approval order statement

approval for transferring the 2 mL BioGlue Surgical Adhesive fill from the currently approved 5 mL syringe body to the larger 10 mL syringe body and requested to extend the shelf life from 21 to 24 months for the 2 mL configuration.
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Cardiovascular
Decision date
Jul 15, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P010003/S043
Regulatory pathway
PMA supplement
Product code
MUQ
Decision code
APPR
Decision date
Jul 15, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Glue, surgical, arteries.

Product code
MUQ
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P010003/S043 received

    Application receipt date recorded by FDA.

  2. P010003/S043 · FDA decision

    Real-Time Process

Timeline entries are records held by MedtechLedger for P010003. View FDA’s full supplement list.

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Cryolife, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
1655 Roberts Blvd. NW, Kennesaw, GA, 30144

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records